Physician profile
Laurie E Cohen
NPI 1639254485
$27,491.96
in general payments reported to CMS, 2019-2025
11 companies · $14.41 in 2025
The $14.41 reported for 2025 was less than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13K · 2021: $2,720 · 2023: $246 · 2024: $12K · 2025: $14.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,296 · Consulting Fee: $5,156 · Food and Beverage: $483 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,295.84 |
| Consulting Fee | $5,156.25 |
| Food and Beverage | $482.60 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk Health Care Ag | $16,806.07 | 2020-2024 | |
| Sandoz INC. | $10,425.00 | 2020 | |
| Ascendis Pharma Endocrinology INC | $176.80 | 2023 | |
| Novo Nordisk INC | $32.27 | 2023 | Sogroya |
| Acadia Pharmaceuticals INC | $19.68 | 2023 | Daybue |
| Alk-Abello, INC | $17.73 | 2023 | Odactra, Ragwitek, Grastek |
| Cranial Technologies, INC | $14.41 | 2025 | Doc Band |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurie Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.